The Journal apologises, as does Dr Calton (British Journal of Psychiatry, 2005), for giving the impression that the views expressed by authors were influenced by their occasional support from pharmaceutical companies. Your column (Reference TyrerTyrer, 2005) comments that assuming that such support necessarily creates a conflict of interest is ‘sometimes’ unwarranted. I am sure that it would be of great interest to readers to know how you judge when such an assumption is warranted. Does it depend on how often you receive support? Or on the financial value of such support? Or on some multiplication of both? Or on the obviousness of the relationship between the support and the views expressed? We must be told.
eLetters
No eLetters have been published for this article.